Articles Mentioning Pharmaceuticals Stocks

Results 1 - 10 of 934 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Pharmaceuticals

Investing | October 26, 2014

How Gilead Sciences Inc. Isn't Gouging Hepatitis C Patients, in 1 Simple Infographic

Gilead Sciences' Harvoni is actually cheaper than other treatments.

Investing | October 21, 2014

Is It Time to Buy Eli Lilly & Co.'s Stock?

Eli Lilly & Co. is promising big things, but has optimism in the stock gotten ahead of reality? It's time to ask if now's the right time to invest.

Investing | October 10, 2014

Amgen, Inc. Gives AbbVie Inc the Highest Form of Flattery

Amgen is developing a biosimilar of AbbVie's Humira.

Investing | October 04, 2014

Gilead Sciences, Inc. Got 2 Drugs Approved, and Didn't Bother to Tell Anyone

Gilead Science's Tybost and Vitekta are already part of its approved quad pill Stribild.

Dividends & Income Investing | October 04, 2014

Better Dividend Stock: GlaxoSmithKline PLC or AstraZeneca PLC?

U.K.-based Big Pharma stocks GlaxoSmithKline and AstraZeneca have some of the juiciest dividends within the healthcare sector; but how sustainable are these yields? Find out which of these two is the better dividend stock.

Investing | October 02, 2014

Why Allergan Inc. Is an Activist Investor Target

Botox-maker Allergan has attracted activist investors in droves lately. Here's why.

Investing | September 30, 2014

Big News for These 5 Stocks From ESMO

But smaller biotechs Clovis Oncology and Exelixis also benefit from the big boys' data.

Investing | September 22, 2014

Surprising Silver Lining for Gilead Sciences, inc. Stock

There's a silver lining in CVS's data on Gilead Sciences' Sovaldi.

Investing | September 19, 2014

3 Biotechs Investors Should Watch

The healthcare version of Where the Money Is.

Investing | September 04, 2014

Merck & Co., Inc. Wins First Stage of the PD-1 Race

Merck gains FDA approval for Keytruda, but the race isn't over yet.

Results 1 - 10 of 934 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Pharmaceuticals